During the past decade, Polyclinique Kenval ; Radiotherapie Oncologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique Kenval ; Radiotherapie Oncologie" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique Kenval ; Radiotherapie Oncologie" are "B-cell Lymphoma" (1 trials), "Breast Cancer" (1 trials), "Hepatocellular Carcinoma" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Polyclinique Kenval ; Radiotherapie Oncologie" in a lesser frequency.

Most popular intervention types in "Polyclinique Kenval ; Radiotherapie Oncologie" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Atezolizumab" (1 trials), "CHOP" (1 trials), "Placebo" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique Kenval ; Radiotherapie Oncologie" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Polyclinique Kenval ; Radiotherapie Oncologie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Polyclinique Kenval ; Radiotherapie Oncologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique Kenval ; Radiotherapie Oncologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".